Narrow search
Showing 1 - 7 of 7
Cover Image
Quantifying gains in the war on cancer due to improved treatment and earlier detection
Seabury, Seth A.; Goldman, Dana P.; Gupta, Charu N.; … - In: Forum for health economics & policy : an evolving … 19 (2016) 1, pp. 14-139
Persistent link: https://www.econbiz.de/10011537383
Cover Image
Does Medicare coverage improve cancer detection and mortality outcomes?
Myerson, Rebecca Mary; Tucker-Seeley, Reginald; … - 2019
Persistent link: https://www.econbiz.de/10012121070
Cover Image
An economic evaluation of the war on cancer
Lakdawalla, Darius N.; Sun, Eric C.; Jena, Anupam B.; … - In: Journal of health economics 29 (2010) 3, pp. 333-346
Persistent link: https://www.econbiz.de/10008662658
Cover Image
The potential impact of comparative effectiveness research on US health care expenditures
Perlroth, Daniella J.; Goldman, Dana P.; Garber, Alan M. - In: Demography : a publication of the Population … 47 (2010), pp. 173-190
Persistent link: https://www.econbiz.de/10008934892
Cover Image
Comparing medical productivity between Germany and the US : an assessment of differences and trends in costs, treatments and outcomes for acute myocardial infarction and colorectal...
Vries, Han de; Goldman, Dana P.; Joyce, Geoffrey - 2008 - 1. Aufl.
Persistent link: https://www.econbiz.de/10003763693
Cover Image
An Economic Evaluation of the War on Cancer
Sun, Eric C. - 2018
For decades, the US public and private sectors have committed substantial resources towards cancer research, but the … societal payoff has not been well-understood. We quantify the value of recent gains in cancer survival, and analyze the … distribution of value among various stakeholders. Between 1988 and 2000, life expectancy for cancer patients increased by roughly …
Persistent link: https://www.econbiz.de/10012940684
Cover Image
An Economic Evaluation of the War on Cancer
Sun, Eric C. - 2009
For decades, the US public and private sectors have committed substantial resources towards cancer research, but the … societal payoff has not been well-understood. We quantify the value of recent gains in cancer survival, and analyze the … distribution of value among various stakeholders. Between 1988 and 2000, life expectancy for cancer patients increased by roughly …
Persistent link: https://www.econbiz.de/10012463075